Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
Stroke Trial Links
Government Sites
Independent Sites
News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback
Search for Trials
PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Enoxaparin
Lovenox® Clexane®

Action
Low-molecular-weight heparin.

Status
US FDA approved for deep venous thrombosis, unstable angina and non-Q wave myocardial infarcton. Status of stroke trial development unknown.

Trial(s)
  = Ongoing
  = Completed

Enoxaparin vs heparin for prevention of deep-vein thrombosis in acute ischaemic stroke: a randomized, double-blind study.
PREVAIL PREvention of VTE after Acute Ischemic Stroke with LMWH or Enoxaparin.

Web Links and Publications
Enoxaparin Patient Information (MEDLINEplus).
Aventis Web Site.
Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke (Cochrane Review).
Cochrane Database Syst Rev. 2001;4:CD000119.

UID: 19

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2010 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, March 12, 2010